Literature DB >> 28215487

Executive summary of management of prosthetic joint infections. Clinical practice guidelines by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

Javier Ariza1, Javier Cobo2, Josu Baraia-Etxaburu3, Natividad Benito4, Guillermo Bori5, Javier Cabo6, Pablo Corona7, Jaime Esteban8, Juan Pablo Horcajada9, Jaime Lora-Tamayo10, Oscar Murillo11, Julián Palomino12, Jorge Parra13, Carlos Pigrau14, José Luis Del Pozo15, Melchor Riera16, Dolores Rodríguez14, Mar Sánchez-Somolinos17, Alex Soriano18, M Dolores Del Toro19, Basilio de la Torre20.   

Abstract

The incidence of prosthetic joint infection (PJI) is expected to increase in the coming years. PJI has serious consequences for patients, and high costs for the health system. The complexity of these infections makes it necessary to organize the vast quantity of information published in the last several years. The indications for the choice of a given surgical strategy and the corresponding antimicrobial therapy are specifically reviewed. The authors selected clinically relevant questions and then reviewed the available literature in order to give recommendations according to a pre-determined level of scientific evidence. The more controversial aspects were debated, and the final composition was agreed at an ad hoc meeting. Before its final publication, the manuscript was made available online in order that all SEIMC members were able to read it and make comments and suggestions.
Copyright © 2016 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Entities:  

Keywords:  Arthroplasty infection; Guidelines; Guía clínica; Infección de artroplastia; Infección de prótesis articular; Prosthetic joint infection

Mesh:

Year:  2017        PMID: 28215487     DOI: 10.1016/j.eimc.2016.08.012

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  21 in total

1.  Uniplanar versus biplanar monolateral external fixator knee arthrodesis after end-stage failed infected total knee arthroplasty: a comparative study.

Authors:  Pablo S Corona; Maria Jurado; Ana Scott-Tennent; Rosa Fraile; Luis Carrera; Matías Vicente
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-02-04

2.  Use of modular megaprosthesis in managing chronic end-stage periprosthetic hip and knee infections: Is there an increase in relapse rate?

Authors:  Pablo S Corona; Matias Vicente; Mireia Lalanza; Carles Amat; Luis Carrera
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-01-24

3.  Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections.

Authors:  L Morata; J Cobo; M Fernández-Sampedro; P Guisado Vasco; E Ruano; J Lora-Tamayo; M Sánchez Somolinos; P González Ruano; A Rico Nieto; A Arnaiz; M Estébanez Muñoz; M E Jiménez-Mejías; A B Lozano Serrano; E Múñez; D Rodriguez-Pardo; R Argelich; A Arroyo; J M Barbero; F Cuadra; A Del Arco; M D Del Toro; L Guio; D Jimenez-Beatty; N Lois; O Martin; R M Martínez Alvarez; F J Martinez-Marcos; L Porras; M Ramírez; J Vergas García; A Soriano
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

4.  Streptococcal and Staphylococcus aureus prosthetic joint infections: are they really different?

Authors:  Yousra Kherabi; Valérie Zeller; Younes Kerroumi; Vanina Meyssonnier; Beate Heym; Olivier Lidove; Simon Marmor
Journal:  BMC Infect Dis       Date:  2022-06-17       Impact factor: 3.667

Review 5.  Intravenous antibiotic duration in the treatment of prosthetic joint infection: systematic review and meta-analysis.

Authors:  Nour Bouji; Sijin Wen; Matthew J Dietz
Journal:  J Bone Jt Infect       Date:  2022-09-19

6.  Arthroscopic "Debridement and Implant Retention" With Local Administration of Exebacase (Lysin CF-301) Followed by Suppressive Tedizolid as Salvage Therapy in Elderly Patients for Relapsing Multidrug-Resistant S. epidermidis Prosthetic Knee Infection.

Authors:  Tristan Ferry; Cécile Batailler; Aubin Souche; Cara Cassino; Christian Chidiac; Thomas Perpoint; Claire le Corvaisier; Jérôme Josse; Romain Gaillard; Julien Roger; Camille Kolenda; Sébastien Lustig; Frédéric Laurent
Journal:  Front Med (Lausanne)       Date:  2021-05-14

7.  Medical innovations to maintain the function in patients with chronic PJI for whom explantation is not desirable: a pathophysiology-, multidisciplinary-, and experience-based approach.

Authors:  Tristan Ferry; Cécile Batailler; Sophie Brosset; Camille Kolenda; Sylvain Goutelle; Elliot Sappey-Marinier; Jérôme Josse; Frédéric Laurent; Sébastien Lustig
Journal:  SICOT J       Date:  2020-07-07

8.  Daptomycin Plus Fosfomycin as Salvage Therapy in a Difficult-to-Treat Total Femoral Replacement Infection.

Authors:  Gonzalo Luengo; Jaime Lora-Tamayo; Diana Paredes; Irene Muñoz-Gallego; Antonio Díaz; Emilio Delgado
Journal:  J Bone Jt Infect       Date:  2018-10-04

Review 9.  Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review.

Authors:  Luis Buzón-Martín; I Zollner-Schwetz; Selma Tobudic; Emilia Cercenado; Jaime Lora-Tamayo
Journal:  Antibiotics (Basel)       Date:  2021-05-31

10.  Dalbavancin combined with linezolid in prosthetic-hip infection.

Authors:  I M Carrión Madroñal; R Sánchez Del Moral; J M Abad Zamora; F J Martínez Marcos
Journal:  Rev Esp Quimioter       Date:  2020-03-11       Impact factor: 1.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.